Faringhomed (Pharyngomed)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbsplozenges
Composition:

Active components: Phytolacca americana (Phytolacca) (Phytolyacca americana (Phytolyacca)) C24, Atropa belladonna (Belladonna) (Atropa Belladonna (Belladonna)) C30, Hepar sulfuris (Gepar sulfuris) C12, Acidum silicicum (Silicea) (Acidum Silicium (Silicea)) C12.

Excipients: isomalt 0.506 g, microcrystalline cellulose 0.0275 g, magnesium stearate 0.0055 g, citric acid anhydrous 0.005225 g, silicon dioxide colloid 0.00275 g, sodium cyclamate 0.00275 g, sodium saccharin 0.000275 g.

Description:

Tablets are flat-cylindrical, with a risk and chamfer, from white to almost white. On the flat side with the risk of inscription MATERIA MEDICA, on the other flat side there is an inscription FARINGOMED.

Pharmacotherapeutic group:homeopathic remedy
ATX: & nbsp
  • Not assigned
    • Pharmacodynamics:

    Has analgesic and anti-inflammatory effect. Reduces swelling, redness, sensation of perspiration and sore throat, facilitates nasal breathing, reduces the likelihood of complications from ENT organs.

    Indications:

    Treatment of inflammatory diseases of the pharynx in adults and children older than 5 years, including in the complex therapy.

    Contraindications:

    Increased individual sensitivity to the components of the drug, children under 5 years of age (due to lack of experience in clinical use).

    Pregnancy and lactation:

    The safety of the use of Tharangomed in pregnancy and during lactation has not been studied. If necessary, taking the drug should take into account the risk / benefit ratio.

    Dosing and Administration:

    At the reception one tablet is kept in the mouth until it dissolves completely. It is advisable to start taking the drug when the first signs of the disease appear.

    The drug is taken as follows: the first 2 hours of treatment - 1 tablet every hour, then 1 tablet every 3-4 hours, but not more than 5 tablets per day.

    If the expressed symptoms of the disease persist within 24 hours of the start of treatment, the drug should be consulted by a doctor.

    Side effects:

    When used for the indicated indications in the indicated dosages, the side effect has not been revealed so far.

    Possible reactions of increased individual sensitivity to the components of the drug.

    Overdose:In case of an accidental overdose, dyspepsia is possible due to the excipients included in the formulation.
    Interaction:

    There have been no incidents of incompatibility with other drugs to date.

    Effect on the ability to drive transp. cf. and fur:Faringhomed does not affect the ability to drive vehicles and other potentially dangerous mechanisms.
    Form release / dosage:Lozenges.
    Packaging:

    For 10 tablets in a planar cell packaging made of polyvinylchloride film and aluminum foil.

    For 1, 2 or 5 contour mesh packages together with the instruction for medical use are placed in a pack of cardboard.

    Storage conditions:At a temperature of no higher than 25 ° C.
    Keep out of the reach of children.
    Shelf life:

    3 years.

    Do not use at the end of the expiration date printed on the package.

    Terms of leave from pharmacies:Without recipe
    Registration number:LSR-007921/09
    Date of registration:06.10.2009 / 26.12.2012
    The owner of the registration certificate:NPF Materia Medica Holding, OOO NPF Materia Medica Holding, OOO Russia
    Manufacturer: & nbsp
    Representation: & nbspNPF Materia Medica Holding LLC NPF Materia Medica Holding LLC Russia
    Information update date: & nbsp22.03.2016
    Illustrated instructions
      Instructions
      Up